TLRY - Tilray Brands, Inc.

7.06
-0.240   -3.399%

Share volume: 3,492,799
Last Updated: 03-05-2026
Pharmaceutical Products/Medicinal Chemicals: 2.23%

PREVIOUS CLOSE
CHG
CHG%
$7.30
-0.24
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
55%
Profitability 50%
Dept financing 36%
Liquidity 31%
Performance 70%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.11%
1 Month
-6.86%
3 Months
-1.94%
6 Months
530.36%
1 Year
944.69%
2 Year
785.38%
Key data
Stock price
$7.06
P/E Ratio 
0.00
DAY RANGE
$6.97 - $7.38
EPS 
-$2.73
52 WEEK RANGE
$0.35 - $15.70
52 WEEK CHANGE
$917.73
MARKET CAP 
912.888 M
YIELD 
N/A
SHARES OUTSTANDING 
116.507 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-28-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$2,685,408
AVERAGE 30 VOLUME 
$2,788,884
Company detail
CEO: Irwin D. Simon
Region: US
Website: tilray.com
Employees: 1,700
IPO year: 2018
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company operates Tilray Medical, which provides GMP-certified flowers, oils, vapes, edibles, and topicals.

Recent news